ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TRB Trinity Biotech Plc

0.00
0.00 (0.00%)
- - Realtime Data
Share Name Share Symbol Market Type
Trinity Biotech Plc TG:TRB Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Rule 8 - Tribal Group Plc

09/07/2003 10:54am

UK Regulatory


RNS Number:3369N
JP Morgan Fleming Asset Mgmnt(UK)Ld
09 July 2003



                                                                    FORM 8.1/8.3


        Lodge with Company Announcements Office (which will publicise and copy
        to the Panel).

        Use separate form for each class of securities in which dealings have
        been made.


     Date of disclosure 9th July 2003


DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3
OF THE CITY CODE ON TAKE-OVERS AND MERGERS


Date of dealing     8th July 2003


Dealing in      Tribal Group Plc     (name of company)


        (1) Class of securities (eg ordinary shares)       Tribal Group Ord 5p



        (2) Amount bought


     25,000



        Amount Sold


     0



        Price per unit


     323.5 p



(3) Resultant total of the same class owned or controlled
(and percentage of class)      1,113,892     (     2.12     %)


(4) Party making disclosure J.P. Morgan Fleming Asset Management (UK)Limited


(5) EITHER     (a) Name of purchaser/vendor (Note 1)

       OR      (b) If dealing for discretionary client(s), name of fund management
                   organisation

                   J.P. Morgan Fleming Asset Management (UK) Limited


(6) Reason for disclosure (Note 2)

     (a) associate of      (i) offeror (Note 3)           NO

                          (ii) offeree company            NO


     Specify which category or categories of associate (1-8)


     If category (8), explain


     (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more
         of the class of relevant securities dealt in)      YES


Signed, for and on behalf of the party named in (4) above


(Also print name of signatory)      Sara Moth


Telephone and extension number      020 7325 5808


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DCCKKLBBXDBEBBL

1 Year Trinity Biotech Chart

1 Year Trinity Biotech Chart

1 Month Trinity Biotech Chart

1 Month Trinity Biotech Chart

Your Recent History

Delayed Upgrade Clock